Literature DB >> 8599217

A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules.

M Mikhailov1, K Monastyrskaya, T Bakker, P Roy.   

Abstract

The development of particular vector systems for the presentation of immunogenic epitopes provides a powerful approach for the delivery of antigens. These include the core-like particles formed by recombinant bluetongue virus (BTV) capsid proteins VP3 and VP7 synthesized in insect cells by recombinant baculoviruses. Previously we have reported localization of an antigenic site on the surface of tubular structures formed by the nonstructural protein NS1 of BTV, and their potential use for epitope presentation. In this study foreign sequences ranging form 44 to 116 aa in length and representing 44 aa sequence from Clostridium difficile toxin A, 48 aa of the hepatitis B virus preS2 region, and the whole of bovine leukemia virus p15 protein were inserted at the C-terminus of BTV-10 NS1. The chimeric NS1 genes were expressed using recombinant baculoviruses and the ability of the mutated NS1 proteins to form tubules was investigated. All chimeric constructs formed tubular structures which carried the foreign antigenic sequences exposed on the surface of the tubules and were highly immunogenic. When Sf cells were coinfected with three recombinant baculoviruses expressing chimeric NS1 proteins with different epitopes, their simultaneous assembly into the same tubule was demonstrated. This observation opens up the possibility of using recombinant NS1 tubules as carriers for the delivery of multiple epitopes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599217     DOI: 10.1006/viro.1996.0119

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Virus-like particles as vaccine adjuvants.

Authors:  S C Gilbert
Journal:  Mol Biotechnol       Date:  2001-10       Impact factor: 2.695

2.  Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.

Authors:  Natasha Larke; Aileen Murphy; Christoph Wirblich; Denise Teoh; Marie J Estcourt; Andrew J McMichael; Polly Roy; Tomás Hanke
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  Obesity vaccines.

Authors:  Mariana P Monteiro
Journal:  Hum Vaccin Immunother       Date:  2013-12-23       Impact factor: 3.452

4.  Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.

Authors:  Randall J Owens; Chang Limn; Polly Roy
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

6.  Immunization against active ghrelin using virus-like particles for obesity treatment.

Authors:  Sara Andrade; Filipa Pinho; Andreia M Ribeiro; Marcos Carreira; Felipe F Casanueva; Polly Roy; Mariana P Monteiro
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

Review 8.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.